Omnibus IX: EU Proposes 16 Additions to Its List of Prohibited Cosmetic Substances

19 November 2026 · Belab Services Regulatory Affairs Team
Eyelash serums, hair dyes and toothpastes are among the products that could be affected by a proposed amendment to the EU Cosmetics Regulation (EC) No 1223/2009. The draft, known as Omnibus IX on CMR substances and the third Omnibus on cosmetic ingredients, would add 16 entries to Annex II, the list of substances prohibited in cosmetic products. It would also change the conditions of use for several ingredients and preservatives.
The amendment is still at the draft stage. On 17 November 2026, the European Commission published its response to comments from China, clarifying the proposed timelines for reformulation and the sale of existing stock.

Which cosmetic ingredients would the EU prohibit?
Eleven of the proposed entries cover substances classified as carcinogenic, mutagenic or toxic to reproduction (CMR). Examples include ozone, nitrous oxide and tetrahydrofurfuryl methacrylate. The draft envisages applying these changes from 1 February 2027, when the corresponding harmonised classifications become applicable under the CLP Regulation.
The other five entries follow assessments by the Scientific Committee on Consumer Safety (SCCS). They cover Benzophenone-1, Benzophenone-2, the hair dyes Basic Brown 16 and Basic Blue 99, and prostaglandins and their analogues as a group. Brands selling lash or brow serums should check for prostaglandin analogues such as Isopropyl Cloprostenate and Ethyl Tafluprostamide.
What would change for CBD, BHA and other ingredients?
Ingredient | Proposed change |
Cannabidiol (CBD) | Maximum of 0.19% in leave-on, rinse-off and oral care products. The draft would cap Δ9-THC as an impurity at 2.5 ppm and exclude applications that could expose the lungs through inhalation. |
Butylated hydroxyanisole (BHA) | Maximum of 0.07% in leave-on and rinse-off products. The draft excludes oral care products and applications that could expose the lungs through inhalation. |
Hydroxyapatite (nano) | Up to 29.5% in toothpaste and 10% in mouthwash, subject to specifications for particle shape, size and surface characteristics. |
Butylparaben and its salts | Product-specific limits for cosmetics intended for children under 10, with additional conditions for certain formats. |
Thiomersal and phenylmercuric salts | The draft would remove the exemptions that allow their use as preservatives in certain eye-area products. |
The annex submitted to the Council of the EU sets out the full conditions of use.
How long would brands have to reformulate and sell existing stock?
For the changes arising from SCCS assessments, the draft sets two deadlines measured from the regulation’s entry into force:
After 12 months, products that fail to meet the new requirements could no longer be placed on the EU market for the first time.
After 24 months, those products could no longer be made available on the EU market, including through the sale of stock already placed on the market.
The calendar dates will depend on publication of the final regulation in the Official Journal of the European Union.
What should cosmetics brands review now?
At Belab, we would start by checking quantitative formulations and raw material specifications against the draft. The INCI list can flag ingredients for review. Supplier documents are needed to verify concentrations, impurities and nanomaterial characteristics.
If a formulation is affected, identify the relevant batches and work with your Responsible Person to determine whether you need to reformulate, repeat testing or update the Cosmetic Product Safety Report (CPSR), Product Information File (PIF), labelling or Cosmetic Products Notification Portal (CPNP) notification.
Could any of your products be affected? Belab Services can review your formulations and help you plan the changes needed for the EU market.
Official sources





Comments